ArticleJournal of medical signals and sensors2025
Identifying Key Biomarkers in Celiac Disease through Analysis of Microarray Data.
Article in Journal of medical signals and sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Celiac disease (CeD) is a chronic autoimmune condition induced by the consumption of gluten, affecting about 1.4% of the global population. The current diagnostic methods largely rely on serological testing, which may disregard certain biomarkers that are essential for an accurate diagnosis. The objective of the present investigation is to identify significant candidate biomarkers in CeD through using a bioinformatics analysis of microarray data. Methods: We analyzed three datasets of the Gene Expression Omnibus database (GSE112102, GSE113469, and GSE164883) to conduct a comprehensive bioinformatics approach. We performed a meta-analysis of differentially expressed genes (DEGs), constructed gene ontology and pathway analyses, and developed protein-protein interaction networks to identify and analyze hub genes and their associated miRNAs. Results: We detected 165 DEGs (79 upregulated and 86 downregulated). Five key hub genes - STAT1, CDC20, perforin-1, CCL2, and MYC were identified as critical regulators involved in controlling both immune system activity and cell cycle progression. Significantly, important miRNAs, including hsa-miR-155-5p, hsa-miR-145-5p, hsa-miR-18a-5p, hsa-miR-34a-5p, hsa-miR-24-3p, and hsa-miR-146a-5p, were seen to have significant interactions with these hub genes. This emphasizes their potential involvement in the pathogenesis of CeD. Conclusion: The genes identified offer potential as key biomarkers for diagnosing CeD and understanding its molecular mechanisms, creating the path for improved diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.